Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas – Implications for the progression of EGFR-mutated lung adenocarcinomas

• Mai Matsumura,

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Writing – original draft

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  ⨯
• Koji Okudela ,

  Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

  * E-mail: kojixok@yokohama-cu.ac.jp

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  http://orcid.org/0000-0002-7525-4051

  ⨯
• Yu Nakashima,

  Roles Methodology

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  ⨯
• Hideaki Mitsui,

  Roles Conceptualization, Methodology

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  ⨯
• Kaori Denda-Nagai,

  Roles Methodology, Resources

  Affiliation Division of Glycobiologics, Intractable Disease Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan

  ⨯
• Takehisa Suzuki,

  Roles Methodology

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  ⨯
• Hiromasa Arai,

  Roles Resources

  Affiliation Division of Surgery, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Japan

  ⨯
• Shigeaki Umeda,

  Roles Formal analysis, Methodology

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  ⨯
• Yoko Tateishi,

  Roles Methodology

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  ⨯
• Chihiro Koike,

  Roles Methodology

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  ⨯
• Toshiaki Kataoka,

  Roles Methodology

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  ⨯
• Tatsuro Irimura,

  Roles Methodology, Supervision

  Affiliation Division of Glycobiologics, Intractable Disease Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan

  ⨯
• Kenichi Ohashi

  Roles Funding acquisition, Project administration, Supervision

  Affiliation Department of Pathology, Yokohama City University, School of Medicine, Yokohama, Japan

  ⨯